Novartis India Limited reported unaudited standalone earnings results for the fourth quarter and full year ended of March 31, 2016. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 153.61 million compared to INR 202.38 million a year ago. Profit from operations before other income and finance costs was INR 9.62 million compared to INR 16.14 million a year ago. Profit from ordinary activities before tax was INR 30.59 million compared to INR 52.91 million a year ago. Net profit for the period was INR 21.53 million compared to INR 51.94 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 6.73 compared to INR 16.25 a year ago. For the full year, the company reported net sales/income from operations (net of excise duty) of INR 768.42 million compared to INR 845.29 million a year ago. Profit from operations before other income and finance costs was INR 19.75 million compared to loss from operations before other income and finance costs of INR 7.87 million a year ago. Profit from ordinary activities before tax was INR 102.51 million compared to INR 99.56 million a year ago. Net profit for the period was INR 198.61 million compared to INR 79.11 million a year ago. Diluted and basic earnings per share after extraordinary items were INR 62.14 compared to INR 24.75 a year ago. Diluted and basic earnings per share before extraordinary items were INR 20.87 compared to INR 26.28 a year ago.